120 related articles for article (PubMed ID: 11140803)
1. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy.
Christensson M; Pettersson E; Sundqvist KG; Christensson B
Clin Nephrol; 2000 Dec; 54(6):435-42. PubMed ID: 11140803
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Ann Rheum Dis; 2006 Nov; 65(11):1484-9. PubMed ID: 16504995
[TBL] [Abstract][Full Text] [Related]
3. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.
Chavele KM; Shukla D; Keteepe-Arachi T; Seidel JA; Fuchs D; Pusey CD; Salama AD
Arthritis Rheum; 2010 May; 62(5):1539-48. PubMed ID: 20155828
[TBL] [Abstract][Full Text] [Related]
4. T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils.
Iking-Konert C; Vogl T; Prior B; Wagner C; Sander O; Bleck E; Ostendorf B; Schneider M; Andrassy K; Hänsch GM
Rheumatology (Oxford); 2008 May; 47(5):609-16. PubMed ID: 18346977
[TBL] [Abstract][Full Text] [Related]
5. Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis.
Marinaki S; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt WH; Weiss C; van der Woude FJ; Yard BA
Nephrol Dial Transplant; 2006 Jul; 21(7):1825-32. PubMed ID: 16567340
[TBL] [Abstract][Full Text] [Related]
6. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
[TBL] [Abstract][Full Text] [Related]
7. Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.
Chen M; Wang F; Zhao MH
Rheumatology (Oxford); 2009 Apr; 48(4):355-8. PubMed ID: 19181656
[TBL] [Abstract][Full Text] [Related]
8. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
[TBL] [Abstract][Full Text] [Related]
10. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis.
Di Lorenzo G; Pacor ML; Mansueto P; Lo Bianco C; Di Natale E; Rapisarda F; Pellitteri ME; Ditta V; Gioè A; Giammarresi G; Rini GB; Li Vecchi M
J Nephrol; 2004; 17(6):800-7. PubMed ID: 15593054
[TBL] [Abstract][Full Text] [Related]
12. Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up.
Hruskova Z; Rihova Z; Mareckova H; Jancova E; Rysava R; Zavada J; Merta M; Löster T; Tesar V
Arch Med Res; 2009 May; 40(4):276-84. PubMed ID: 19608017
[TBL] [Abstract][Full Text] [Related]
13. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
14. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?
Kälsch AI; Soboletzki M; Schmitt WH; van der Woude FJ; Hochhaus A; Yard BA; Birck R
Clin Exp Immunol; 2008 Mar; 151(3):391-8. PubMed ID: 18190601
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
[TBL] [Abstract][Full Text] [Related]
17. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
19. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; Limburg PC; Kallenberg CG
Arthritis Rheum; 2008 Jul; 58(7):2196-205. PubMed ID: 18576340
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion.
Klaus G; Mostert K; Reckzeh B; Mueller TF
Transplantation; 2003 Dec; 76(12):1719-24. PubMed ID: 14688522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
